{{Rsnum
|rsid=1481012
|Gene=ABCG2
|Chromosome=4
|position=88117930
|Orientation=plus
|GMAF=0.1368
|Gene_s=ABCG2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 80.5 | 18.6 | 0.9
| HCB | 50.4 | 40.9 | 8.8
| JPT | 41.6 | 48.7 | 9.7
| YRI | 99.3 | 0.7 | 0.0
| ASW | 91.2 | 8.8 | 0.0
| CHB | 50.4 | 40.9 | 8.8
| CHD | 45.9 | 46.8 | 7.3
| GIH | 86.1 | 13.9 | 0.0
| LWK | 99.1 | 0.9 | 0.0
| MEX | 62.1 | 32.8 | 5.2
| MKK | 98.7 | 1.3 | 0.0
| TSI | 87.3 | 12.7 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22331829
|Trait=None
|Title=Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.
|RiskAllele=
|Pval=2E-15
|OR=5.1000
|ORtxt=None
}}

{{PMID|18775442}} A gene-wide investigation on polymorphisms in the ABCG2/BRCP transporter and susceptibility to colorectal cancer.

{{PMID Auto GWAS
  |PMID=23263486
  |Trait=Gout
  |Title=Genome-wide association analyses identify 18 new loci associated with serum urate concentrations.
  |RiskAllele=A
  |Pval=2E-32
  |OR=.55
  |ORtxt=[0.46-0.64] unit decrease
  |OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}